4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Muscle Rigidity in 1 studies
4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.
Muscle Rigidity: Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. (From Adams et al., Principles of Neurology, 6th ed, p73)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hernández-López, S | 1 |
Flores, G | 1 |
Rosales, MG | 1 |
Sierra, A | 1 |
Martínez-Fong, D | 1 |
Aceves, J | 1 |
1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Muscle Rigidity
Article | Year |
---|---|
Muscarinic antagonists microinjected into the subthalamic nucleus decrease muscular rigidity in reserpinized rats.
Topics: Anesthetics, Intravenous; Animals; Chloral Hydrate; Cholinergic Antagonists; Electromyography; Locom | 1996 |